Key result
Cardiac autonomic neuropathy linked to ~111% more visceral fat in autoimmune but not type 2 diabetes.
Why the study?
The association between cardiac autonomic neuropathy and body fat distribution has not been fully clarified, particularly regarding potential differences between autoimmune diabetes and type 2 diabetes.
Is cardiac autonomic neuropathy associated with increased ectopic fat distribution in patients with autoimmune diabetes compared to type 2 diabetes?
Cross-Sectional (n=143)
No
Is cardiac autonomic neuropathy associated with increased ectopic fat distribution in patients with autoimmune diabetes compared to type 2 diabetes?
Absolute Event Rate: 530% vs 251%
p-value: p=0.001
Ectopic fat distribution is significantly associated with cardiac autonomic neuropathy in patients with autoimmune diabetes, but not in those with type 2 diabetes, highlighting a distinct cardiometabolic risk profile.
Does not warrant practice change; leaves open distinct pathophysiology in autoimmune versus type 2 diabetes.
BACKGROUND: Cardiac autonomic neuropathy (CAN) is a life-threatening complication of diabetes. While obesity is a well-known risk factor of dysautonomia, the association between CAN and body fat distribution has not been fully clarified, especially in autoimmune diabetes (AD). AIM: To evaluate if the association between CAN and body fat distribution differs between AD and type 2 diabetes (T2D). METHODS: Body fat distribution was evaluated by Dual X-Ray Absorptiometry in 143 people with diabetes (44 with ADand 99 with T2D) undergoing clinical screening for CAN. The association of CAN with markers of ectopic fat distribution was evaluated in multivariate regression models adjusting for confounders and testing for the interaction between diabetes type and CAN. RESULTS: A significant interaction between CAN and diabetes type was found with respect to markers of ectopic fat distribution. Specifically, people with CAN had significantly higher amount of visceral adipose tissue (530 [376-665]g versus 251[189-360]g, p = 0.001), total fat mass (22708[20200-27845]g versus 15434[12981-21879]g, p = 0,016), and trunk-to-leg ratio (0.88 [0.75-1.04] versus 0.70 [0.56-0.78], p = 0,023) compared to those without CAN only in participants with AD, but not in T2D (p-values for interaction < 0.05 for all comparisons). CONCLUSION: Ectopic fat distribution is more strongly associated with CAN in AD than in T2D. This highlights the distinct role of fat distribution in the cardiometabolic health of people with AD, suggesting the need for further studies to better understand the pathophysiology and implications of overweight in this population.
No takes yet. Share an insight, caveat, or question.
Risi et al. (2025) conducted a cross-sectional in Autoimmune and Type 2 Diabetes (n=143). Cardiac autonomic neuropathy (CAN) vs. Without cardiac autonomic neuropathy was evaluated on Visceral Adipose Tissue (VAT) mass in autoimmune diabetes (p=0.001). Cardiac autonomic neuropathy was associated with significantly higher visceral adipose tissue mass (530g vs 251g, p=0.001) in patients with autoimmune diabetes, but not in those with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: